Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 15.26%7.59M | 21.02%3.36M | 1.49%4.43M | -3.54%16.99M | -57.28%3.27M | 120.47%6.58M | 43.90%2.77M | -13.47%4.36M | 69.02%17.61M | 68.14%7.66M |
| Selling and administrative expenses | 15.26%7.59M | 21.02%3.36M | 1.49%4.43M | -3.54%16.99M | -57.28%3.27M | 120.47%6.58M | 43.90%2.77M | -13.47%4.36M | 69.02%17.61M | 57.65%7.66M |
| -General and administrative expense | 15.26%7.59M | 21.02%3.36M | 1.49%4.43M | -3.54%16.99M | -57.28%3.27M | 120.47%6.58M | 43.90%2.77M | -13.47%4.36M | 69.02%17.61M | 57.65%7.66M |
| Operating profit | -15.26%-7.59M | -21.02%-3.36M | -1.49%-4.43M | 3.54%-16.99M | 57.28%-3.27M | -120.47%-6.58M | -43.90%-2.77M | 13.47%-4.36M | -68.09%-17.61M | -68.14%-7.66M |
| Net non-operating interest income (expenses) | 92.75%3.94M | 95.95%1.79M | 160.30%3.12M | 378.25%4.22M | 112.87%66K | 1,579.71%2.04M | 1,369.44%914K | 251.01%1.2M | -370.89%-1.52M | -510.40%-513K |
| Non-operating interest income | 67.51%3.96M | -30.47%1.79M | 13.20%3.12M | 201.57%12.31M | 341.15%4.61M | 75.50%2.36M | 107.57%2.58M | 515.40%2.76M | 454.48%4.08M | 247.18%1.05M |
| Non-operating interest expense | -92.55%24K | --0 | --0 | 44.44%8.09M | 191.66%4.54M | -78.32%322K | 26.58%1.66M | 25.44%1.56M | 3,080.68%5.6M | 785.23%1.56M |
| Other net income (expenses) | -289.64%-7.65M | 333.17%10.81M | 140.22%6.45M | -96.64%185K | -498.46%-9.03M | 134.61%4.03M | 42.22%2.5M | 1,232.91%2.69M | 4,199.22%5.5M | 16,285.71%2.27M |
| Gain on sale of security | -1,553.83%-7.21M | 2,514.29%10.82M | 121.47%190K | -2,514.54%-10.79M | -1,475.14%-9.96M | 184.64%496K | -180.87%-448K | -261.22%-885K | 1,962.50%447K | 5,271.43%724K |
| Other non-operating income (expenses) | -112.36%-437K | -100.14%-4K | 75.35%6.26M | 117.13%10.98M | -39.88%927K | 53.45%3.54M | 145.13%2.94M | 44,525.00%3.57M | 3,226.32%5.06M | --1.54M |
| Income before tax | -2,132.61%-11.3M | 1,351.65%9.25M | 1,178.62%5.15M | 7.66%-12.58M | -107.22%-12.23M | 63.96%-506K | 361.07%637K | 92.14%-477K | -39.18%-13.62M | -32.88%-5.9M |
| Income tax | 114K | -397K | 4.43M | 6.29M | 6.29M | 0 | 0 | 0 | 0 | |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2,155.14%-11.41M | 1,413.97%9.64M | 249.48%713K | -38.55%-18.87M | -213.82%-18.53M | 63.96%-506K | 361.07%637K | 92.14%-477K | -39.18%-13.62M | -32.88%-5.9M |
| Net income continuous operations | -2,155.14%-11.41M | 1,413.97%9.64M | 249.48%713K | -38.55%-18.87M | -213.82%-18.53M | 63.96%-506K | 361.07%637K | 92.14%-477K | -39.18%-13.62M | -32.88%-5.9M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -2,155.14%-11.41M | 1,413.97%9.64M | 249.48%713K | -38.55%-18.87M | -213.82%-18.53M | 63.96%-506K | 361.07%637K | 92.14%-477K | -39.18%-13.62M | -32.88%-5.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2,155.14%-11.41M | 1,413.97%9.64M | 249.48%713K | -38.55%-18.87M | -213.82%-18.53M | 63.96%-506K | 361.07%637K | 92.14%-477K | -39.18%-13.62M | -32.88%-5.9M |
| Diluted earnings per share | -0.02 | 0.02 | 0 | 0.00%-0.05 | -150.00%-0.05 | 0 | 0 | 0 | -25.00%-0.05 | 0.00%-0.02 |
| Basic earnings per share | -0.02 | 0.02 | 0 | 0.00%-0.05 | -150.00%-0.05 | 0 | 0 | 0 | -25.00%-0.05 | 0.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.